Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-07-07 17:45 |
Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Va…
|
English | 314.5 KB | ||
| 2021-07-06 17:45 |
Valneva Strengthens Management Team; Appoints Vincent Dequenne as SVP Operation…
|
English | 302.7 KB | ||
| 2021-07-06 17:45 |
Valneva renforce ses équipes dirigeantes et nomme Vincent Dequenne Vice-Préside…
|
French | 476.1 KB | ||
| 2021-07-01 07:00 |
Valneva poursuit ses discussions avec la Commission Européenne pour son candida…
|
French | 468.4 KB | ||
| 2021-07-01 07:00 |
Valneva Continues Ongoing Discussions with the European Commission for Inactiva…
|
English | 127.9 KB | ||
| 2021-06-23 17:40 |
Valneva annonce l’approbation des résolutions présentées à son Assemblée Généra…
|
French | 558.7 KB | ||
| 2021-06-23 17:40 |
Valneva Announces Successful Outcome of its AGM
|
English | 304.1 KB | ||
| 2021-06-11 18:10 |
Valneva Announces Termination of Liquidity Contract with Oddo BHF and Natixis a…
|
English | 316.0 KB | ||
| 2021-06-11 18:10 |
Valneva annonce la résiliation de son contrat de liquidité avec Oddo BHF et Nat…
|
French | 488.6 KB | ||
| 2021-06-11 10:46 |
Franchissement de seuil
|
French | 204.8 KB | ||
| 2021-06-10 07:00 |
Valneva finalise le recrutement l’étude de Phase 3 sur l’homogénéité des lots c…
|
French | 792.5 KB | ||
| 2021-06-10 07:00 |
Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its C…
|
English | 316.3 KB | ||
| 2021-06-07 18:00 |
Déclaration d’actions et de droits de vote de la société Valneva SE – Mai 2021
|
English | 273.7 KB | ||
| 2021-06-03 19:15 |
Valneva finalise le recrutement de Phase 3 pour son candidat vaccin inactivé co…
|
French | 651.1 KB | ||
| 2021-06-03 19:15 |
Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccin…
|
English | 388.2 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
